Delivery Order SPE2DB22D2005-SPE2DB25FJSV2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,887.66 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed price, non-competitive delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,534.08 by the Defense Logistics Agency on August 19, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram quantities. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 20, 2025. This competitively awarded delivery order, which includes no set-aside designation, is issued under AmerisourceBergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,028.79 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream 30gm, a pharmaceutical product, with a performance period ending on April 18, 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The contract provides for the delivery of PIMECROLIMUS 1% CREAM 60GM, a pharmaceutical product, with a potential value of $1,378.27 and a completion date of March 8, 2024. This award is not associated with any set-aside designation....
- The U.S. Defense Logistics Agency (DLA) awarded a $1,739.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of PIMECROLIMUS 1% Cream (30 grams). This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,033.53 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream, a topical medication. The award has an ultimate completion date of September 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for the delivery of PIMECROLIMUS CREAM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,754.01 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a leading global pharmaceutical distribution company, through its Corporate Office division located in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00, to...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a delivery order contract worth $1,094.44 for the supply of 4566110547 - Pimecrolimus 1% Cream 100 gm. The contract, which has a completion date of October 16, 2024, is a firm fixed-price award with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of essential medical products, including...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Pimecrolimus 1% Cream 30g, a topical medication, and has a ceiling value of $1,539.00. This is a Firm Fixed Price Delivery Order contract with a completion date of November 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
- The Defense Logistics Agency awarded a $82,920 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Pimecrolimus 1% cream. As part of DLA's medical supplies procurement program, this order supports delivery of 30 grams of the topical immunosuppressant cream to a location in Conshohocken, Pennsylvania by July 18, 2023. Amerisourcebergen will serve as the prime contractor, drawing from its extensive distribution network to fulfill this short-term requirement for a specialty...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJSV2Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,138.56 for Pimecrolimus 1% Cream 30GM, a topical immunosuppressant medication commonly used to treat inflammatory skin conditions. Awarded on August 28, 2025, with a completion date of August 29, 2025, this firm fixed-price delivery order represents a competitive award with no set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and federal medical procurement needs worldwide. The company's status as a critical federal pharmaceutical distributor reflects its capability to fulfill diverse medical supply requirements across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/28/25 |